cbdMD (YCBD) Shares Outstanding (2016 - 2026)
cbdMD (YCBD) posted Shares Outstanding (Entity) of $10.1 million for Q4 2025, up 150.35% sequentially from $4.0 million in Q3 2025, and up 1669.85% YoY from $569008.0 in Q4 2024.
cbdMD (YCBD) Shares Outstanding (2016 - 2026) Analysis & Trends
cbdMD has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $10.1 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 1669.85% year-over-year to $10.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.1 million (up 1669.85% YoY) and the FY2025 annual result came in at $4.0 million, up 543.62% from the prior year.
- Shares Outstanding (Entity) advanced to $10.1 million in Q4 2025 per YCBD's latest filing, from $4.0 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $10.1 million in Q4 2025 and troughed at $156478.0 in Q1 2021.
- A 5-year average of $1.3 million and a median of $275122.0 in 2023 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) gained 2.03% in 2023, then jumped 1669.85% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $161867.0 in 2021, then grew by 4.18% to $168628.0 in 2022, then soared by 119.49% to $370118.0 in 2023, then soared by 53.74% to $569008.0 in 2024, then surged by 1669.85% to $10.1 million in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $10.1 million, $4.0 million, and $5.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 832.44 Mn |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 10.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.62 Mn |
| Dec 31, 2025 | 9.00 Mn |
| Sep 30, 2025 | 4.02 Mn |
| Jun 30, 2025 | 5.78 Mn |
| Mar 31, 2025 | 778,410.00 |
| Dec 31, 2024 | 569,008.00 |
| Sep 30, 2024 | 539,068.00 |
| Jun 30, 2024 | 449,121.00 |
| Mar 31, 2024 | 370,132.00 |
| Dec 31, 2023 | 370,118.00 |
| Sep 30, 2023 | 252,790.00 |
| Jun 30, 2023 | 297,454.00 |
| Mar 31, 2023 | 168,199.00 |
| Dec 31, 2022 | 167,643.00 |
| Sep 30, 2022 | 165,956.00 |
| Jun 30, 2022 | 164,752.00 |
| Mar 31, 2022 | 163,781.00 |
| Dec 31, 2021 | 160,610.00 |
| Sep 30, 2021 | 152,591.00 |
| Jun 30, 2021 | 157,418.00 |